A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma

Clinical trial NCT04845139 · UNKNOWN

Trial details

NCT number: NCT04845139
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Refractory Central Nervous System Lymphoma Relapsed Primary Central Nervous System Lymphoma Primary Central Nervous System Lymphoma

Start date: 2022-07-02
Primary completion: 2022-10-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.